Neurokinin-1-Receptor Antagonists: A New Approach in Antiemetic Therapy

Publisher： Karger

E-ISSN： 2296-5262|29|1-2|39-43

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.29, Iss.1-2, 2006-01, pp. : 39-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histamine H4 Receptor Antagonists: A New Approach for Tinnitus Treatment?

By  

Recent Patents on CNS Drug Discovery, Vol. 10, Iss. 1, 2015-01 ,pp. : 6-9

Bentham Science Publishers

Access to resources Recommend Favorite

Combined Effect of Anti-Angiogentic Agents, Angiotensin Type 1 Receptor Antagonists and Radiation Therapy

By  

Current Signal Transduction Therapy, Vol. 5, Iss. 3, 2010-09 ,pp. : 206-211

Bentham Science Publishers

Access to resources Recommend Favorite

Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 21, 2015-11 ,pp. : 5136-5146

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neurokinin–1 Receptor Antagonist Inhibits Short–Term Sulfuric–Acid–Induced Airway Hyperresponsiveness in Sensitized Guinea Pigs

By  

International Archives of Allergy and Immunology, Vol. 121, Iss. 1, 2000-02 ,pp. : 53-56

Karger

Access to resources Recommend Favorite

Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States

By Schwartzberg Lee   Morrow Gary   Balu Sanjeev   Craver Chris   Gayle Julie   Cox David  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1613-1622

Informa Healthcare

Access to resources Recommend Favorite